Mobile

A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis

Update Il y a 4 ans
Reference: EUCTR2005-005292-15

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of this study is to compare the pharmacodynamic effect of a prasugrel 60 mg Loading Dose with a clopidogrel 600 mg Loading Dose, as assessed by change in mean maximal platelet aggregation to 20 mM ADP at 2 hours after LD administration, in aspirin-treated subjects with stable atherosclerosis.

Inclusion criteria

  • Stable atherosclerosis

Links